scholarly journals Malignant Ovarian Serous Tumor

2020 ◽  
Author(s):  
Keyword(s):  
Serous Tumor

The Coexistence of a Primary Ovarian Lymphoma and a Serous Tumor of Low Malignant Potential in the Same Ovary

1994 ◽  
Vol 10 (3) ◽  
pp. 189-192 ◽  
Author(s):  
ALLEN WESCHE ◽  
VIVEK K. KHARE ◽  
JEFFREY McCARTNEY ◽  
DAN C. MARTIN ◽  
J. CAMERON HALL
Keyword(s):  
Malignant Potential ◽  
Low Malignant Potential ◽  
Serous Tumor

Serous Tumor of Low Malignant Potential of the Fallopian Tube

2000 ◽  
Vol 19 (4) ◽  
pp. 398-400 ◽  
Author(s):  
Emre Kayaalp ◽  
Debra S. Heller ◽  
Bhagirath Majmudar
Keyword(s):  
Fallopian Tube ◽  
Malignant Potential ◽  
Low Malignant Potential ◽  
Serous Tumor

Abstract 5530: Rejuvenation of dissociated cryopreserved human ovarian papillary serous tumor cells in anin vivomodel.

2013 ◽  
Author(s):  
Daniel Y. Paik ◽  
Deanna Janzen ◽  
Sanaz Memarzadeh
Keyword(s):  
Tumor Cells ◽  
Serous Tumor

scholarly journals Ovarian sparing cystectomy for borderline serous tumor through vNOTES (vaginal Natural Orifices Transluminal Endoscopic Surgery)

2020 ◽  
Vol 30 (8) ◽  
pp. 1253-1254
Author(s):  
Levon Badiglian-Filho ◽  
Elza Mieko Fukazawa ◽  
Carlos Faloppa ◽  
Glauco Baiocchi
Keyword(s):  
Endoscopic Surgery ◽  
Serous Tumor ◽  
Natural Orifices

Assessing the landscape of ovarian serous borderline tumors

2019 ◽  
Vol 29 (3) ◽  
pp. 572-578 ◽  
Author(s):  
Irini Messini ◽  
Triada Doulgeraki ◽  
Dimitris Chrysanthakis ◽  
Petros Yiannou ◽  
Theofani Gavresea ◽  
...  
Keyword(s):  
Univariate Analysis ◽  
Lymph Node Involvement ◽  
Serous Carcinoma ◽  
Low Grade ◽  
Borderline Tumors ◽  
Non Invasive ◽  
Node Involvement ◽  
Serous Tumor ◽  
Serous Tumors ◽  
Micropapillary Pattern

AimTo compare distinct clinicopathological features between atypical proliferative serous tumors and non-invasive low-grade ovarian serous carcinomas.MethodsOur study group comprised 203 cases of serous borderline tumors sub-classified as atypical proliferative serous tumors or as non-invasive low-grade serous carcinomas. All pathological features related to borderline tumors were re-evaluated by two gynecological pathologists. Data concerning recurrences and survival were retrieved from the medical records of the patients.ResultsWhen comparing atypical proliferative serous tumors to non-invasive low-grade serous carcinomas, the latter were statistically related to advanced stage at diagnosis, bilateral disease, exophytic pattern of growth, microinvasive carcinoma, and the presence of invasive implants. In univariate analysis, recurrences were statistically related to the exophytic pattern of growth, to microinvasion, and to the presence of implants (both invasive and non-invasive). Nevertheless, in multivariate analysis, only microinvasion and the presence of invasive implants were related to recurrence. Women who eventually succumbed to the disease were only those with invasive implants. Their ovarian tumor was either a non-invasive low-grade serous carcinoma or an atypical proliferative serous tumor with ‘minimal’ micropapillary pattern. Neither lymph node involvement nor endosalpingiosis seemed to influence the course of the disease.ConclusionsThe results of our study underline the increased possibility of non-invasive low-grade serous carcinomas to be related with features indicative of aggressive behavior as opposed to atypical proliferative serous tumors. Nevertheless, irrespective of tumor histology, the presence of invasive implants and microinvasion were the only independent prognostications of recurrence.

miRNA‐301b‐3p accelerates migration and invasion of high‐grade ovarian serous tumor via targeting CPEB3/EGFR axis

2019 ◽  
Vol 120 (8) ◽  
pp. 12618-12627 ◽  
Author(s):  
Fengying Liu ◽  
Guilian Zhang ◽  
Shiming Lv ◽  
Xinmian Wen ◽  
Peishu Liu
Keyword(s):  
Migration And Invasion ◽  
High Grade ◽  
Serous Tumor

Borderline Papillary Serous Tumor of the Right Ovary

Radiographics ◽  
2005 ◽  
Vol 25 (6) ◽  
pp. 1689-1692 ◽  
Author(s):  
Kimberly J. Burkholz ◽  
Beverly P. Wood ◽  
Craig Zuppan
Keyword(s):  
Serous Tumor ◽  
The Right

scholarly journals Microangiopathic Hemolytic Anemia in 57-year-old woman with Borderline Serous Tumor of the Ovary:Real-Time Management of Common Pathways of Hemostatic Failure

2012 ◽  
Vol 4 (1) ◽  
pp. e2012030
Author(s):  
Gloria Joan Morris
Keyword(s):  
Hemolytic Anemia ◽  
Time Management ◽  
Clinical Information ◽  
Coagulation System ◽  
Ovarian Mass ◽  
Common Pathway ◽  
Diagnostic Dilemma ◽  
Heparin Induced Thrombocytopenia ◽  
Strategic Approach ◽  
Serous Tumor

We present a case of a 57-year-old woman who underwent surgery for the removal of an ovarian mass but subsequently experienced microangioathic hemolytic anemia post-operatively, associated with fevers, renal insufficiency, hypertension, and hemolysis. While her clinical situations was initially suspicious for thrombotic thrombocytopenic purpura (TTP), further sorting of clinical information led to other explanations of these findings, including a systemic inflammatory response. Multiple triggers of the coagulation system which can lead to a common pathway of hemostatic failure were considered, and specific criteria seen in disseminated intravascular coagulation (DIC), TTP, heparin-induced thrombocytopenia (HIT), catastrophic antiphospholipid anitbody syndrom (APS), all of which can seem to overlap when a physician is faced with distinguishing the diagnosis clinically. We propose a chronologic and strategic approach for the clinician to consider when approaching this diagnostic dilemma.

Clinical outcome and risk factors for recurrence in borderline ovarian tumors

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 16020-16020
Author(s):  
Y. Yokoyama ◽  
H. Mizunuma ◽  
N. Yaegashi ◽  
T. Tanaka ◽  
H. Kurachi ◽  
...  
Keyword(s):  
Risk Factors ◽  
Survival Rate ◽  
Disease Free Survival ◽  
Conservative Surgery ◽  
Free Survival ◽  
Borderline Ovarian Tumors ◽  
Risk Factors For Recurrence ◽  
Serous Tumor ◽  
Disease Free Survival Rate ◽  
Disease Free

16020 Background: We investigated the long-term prognosis of borderline ovarian tumors and determined risk factors for recurrence. Methods: One hundred and twenty one borderline ovarian tumors treated between 1994 and 2003 at the participating institutions in the Tohoku Gynecologic Cancer Unit were retrospectively investigated for clinical stage, histopathological subtype, surgical technique, postoperative chemotherapy, the presence or absence of recurrence, and prognosis. Results: The median follow-up period was 57 months (1–126 months). One hundred and nine cases (90.6%) were at clinical stage I. The histopathological subtypes consisted of 91 cases of mucinous tumor (75.2%), 27 cases of serous tumor (22.3%), and 3 cases of endometrioid tumor. Conservative surgery was used in 53 cases (43.8%), radical surgery in 68 cases (56.2%), a staging laparotomy in 43 cases (35.5%), and postoperative adjuvant therapy in 30 cases (24.8%). Recurrence was found in 8 cases, but no tumor-related deaths were reported. Although no significant difference in disease free survival rate was seen between different clinical stages, the difference in disease free survival rate between serous and non-serous (mucinous and endometrioid) types was significant (p<0.05). The 10-year disease free survival rate was 89.1% for the radical surgery group, and 57.4% for the conservative surgery group- this difference was significant (p<0.05). In the conservative surgery group, cystectomy and serous tumor were independent risk factors for recurrence. Although recurrence was observed, the long-term prognosis of borderline ovarian tumor was favorable, without tumor-related deaths. Conclusion: Considering the favorable prognosis, conservative surgery can be chosen as far as the patient has a non-serous tumor and receive adnexectomy. However, in cases of serous type and/or receiving cystectomy special care should be given as relative risk rates of recurrence elevate by 2 to 4 folds. No significant financial relationships to disclose.

Cutaneous involvement by an ovarian serous tumor of low malignant potential

1991 ◽  
Vol 70 (7-8) ◽  
pp. 625-628 ◽  
Author(s):  
Theresa Dugan ◽  
Gulnar Balsara ◽  
Charles J. Dunton ◽  
Enrique Hernandez
Keyword(s):  
Malignant Potential ◽  
Cutaneous Involvement ◽  
Low Malignant Potential ◽  
Serous Tumor
Sign in / Sign up

Export Citation Format

Share Document